SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-009873
Filing Date
2017-05-09
Accepted
2017-05-09 16:18:23
Documents
61
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arna-10q_20170331.htm 10-Q 1297186
2 EX-10.1 arna-ex101_12.htm EX-10.1 25384
3 EX-10.2 arna-ex102_8.htm EX-10.2 4886
4 EX-10.3 arna-ex103_13.htm EX-10.3 145218
5 EX-31.1 arna-ex311_9.htm EX-31.1 15019
6 EX-31.2 arna-ex312_10.htm EX-31.2 15408
7 EX-32.1 arna-ex321_6.htm EX-32.1 8772
  Complete submission text file 0001564590-17-009873.txt   4866891

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT arna-20170331.xml EX-101.INS 878844
9 XBRL TAXONOMY EXTENSION SCHEMA arna-20170331.xsd EX-101.SCH 46121
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arna-20170331_cal.xml EX-101.CAL 39985
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arna-20170331_def.xml EX-101.DEF 150873
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20170331_lab.xml EX-101.LAB 327396
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20170331_pre.xml EX-101.PRE 242812
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 17826672
SIC: 2834 Pharmaceutical Preparations